Market Cap

Flexion Therapeutics, Inc. Market Capitalization:

$0

USD as of Jan. 1, 2026

business Flexion Therapeutics, Inc. Company Profile

Flexion Therapeutics, Inc. Main Stock Listing

NASDAQ: FLXN

Market Capitalization History of Flexion Therapeutics, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
MERCK Kommanditgesellschaft auf Aktien $62.01 B
Zoetis Inc. $55.81 B
Takeda Pharmaceutical Company Limited $45.42 B
Haleon plc $44.50 B
Teva Pharmaceutical Industries Limited $35.85 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Flexion Therapeutics, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2026 $0

Market capitalization is calculated from the opening stock price at the beginning of each year.

Flexion Therapeutics, Inc. Categories

United States languages Healthcare languages Drug Manufacturers—Specialty & Generic
United States Healthcare United States Drug Manufacturers—Specialty & Generic

Stocks & Indices

Flexion Therapeutics, Inc. has the following listings and related stock indices.


Stock: NASDAQ: FLXN

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.